US-based LabStyle Innovations announced that the world roll-out of the Dario diabetes management platform is now in progress with today's market launch of the Dario iOS app in the UK, New Zealand and Australia.

LabStyle Innovations is the developer of Dario, a cloud-based, mobile health (mHealth) platform for diabetes and related blood glucose monitoring.

Customers in these countries are invited to download the complimentary app from the Apple App Store. The app works with all blood glucose monitoring devices. By simply manually inputting blood glucose information, customers will be able to experience the novel functionality and benefits of Dario’s iOS app.

LabStyle Innovations executive chairman and co-founder Dr Oren Fuerst noted the complete Dario platform is designed to capture the full diabetic landscape from monitoring to therapy.

"We also believe Dario™ is the only end-to-end mobile health platform that encourages compliance by offering people living with diabetes a new way to understand and control their condition. We are all extremely excited about today’s launch and achieving this important milestone in just 28 months since our founding.

"We very much look forward to continuing the world roll-out of the complete Dario platform throughout 2014 in Europe and selected areas in the Asia-Pacific region and, assuming regulatory approval, later in 2014, in the U.S," Fuerst added.

The Dario diabetes management platform includes the novel Dario app (currently available for iOS and to be available in 2014 for Android), website software, and a stylish, ‘all-in-one’, pocket-sized, Dario blood glucose monitoring device, which comes complete with lancet, strips and a glucose meter.

The glucose meter connects to a smartphone and the feature rich Dario mobile and website applications enabling patients, medical professionals and caregivers to access and analyze data in real time.

LabStyle remains on course to launch the Dario iOS app in Italy and Belgium and the Dario Android app, in the UK, New Zealand, Australia, Italy and Belgium – both during first quarter 2014.

Plans are also on track to soft launch the Dario all-in-one blood glucose monitoring device in the UK, Italy, Belgium, New Zealand and Australia during first quarter 2014.